Presenter: Ramzi Abboud, MD

Title: Optimizing CyTOF Correlative Studies from the clinical trial – “JAK Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome after T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation”

The IML team will also briefly cover recent updates.

Zoom link will be sent to all signed up for the CyTOF listserv.

Please contact Amy Johnson at aljohnson@wustl.edu with any questions.